Does Dr. MAHMOUD ABU GHANAM have financial conflicts of interest?

Dr. MAHMOUD ABU GHANAM (MD) has received a total of $594 in pharmaceutical and medical device industry funding between 2021 and 2024. This includes $594 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. MAHMOUD ABU GHANAM?

According to CMS Open Payments data, Dr. MAHMOUD ABU GHANAM received funding from CURONIX ($344), BOSTON SCIENTIFIC CORPORATION ($211), and COLLEGIUM PHARMACEUTICAL ($39).

Does Dr. MAHMOUD ABU GHANAM receive research grants or speaking fees?

Dr. MAHMOUD ABU GHANAM has received $594 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. MAHMOUD ABU GHANAM

MDReal-Time Hydrated

Specialty: Pain Medicine, Interventional Pain Medicine

Practice Location: LIBERTY, NY 12754

NPI Number: 1912952540

LIFETIME INDUSTRY VALUE

$594

2021 – 2024 Cumulative

Conflict of Interest Analysis

Dr. ABU GHANAM is a verified Pain Medicine, Interventional Pain Medicine practitioner based in LIBERTY, NY.

Between 2021 and 2024, Dr. ABU GHANAM had an overall industry promotional and research financial footprint of $594 as recorded in the federal CMS Open Payments database.

$594 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. ABU GHANAM's primary funding source is CURONIX, which accounts for $344 (representing 57.9% of overall industry footprint).

Data coverage: 2021 – 2024 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

CURONIX

Rank 1

$344

57.9%

BOSTON SCIENTIFIC CORPORATION

Rank 2

$211

35.5%

COLLEGIUM PHARMACEUTICAL

Rank 3

$39

6.7%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2024

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.